Esperion’s Bempedoic Acid Receives Multiple Class 1 Recommendations in 2026 ACC/AHA Multisociety Guideline for Management of Dyslipidemia

AI Briefing

• – Bempedoic acid receives top class 1 recommendation from AHA/ACC for patients with statin intolerance and severe hypercholesterolemia.
• – The medication is also recommended for primary and secondary prevention in patients with severe hypercholesterolemia.
• – This endorsement reflects a significant development in the treatment of dyslipidemia.